CPRX
Catalyst Pharmaceuticals Inc
NASDAQ: CPRX · HEALTHCARE · BIOTECHNOLOGY
$28.26
-4.01% today
Updated 2026-04-29
Market cap
$3.45B
P/E ratio
16.82
P/S ratio
5.86x
EPS (TTM)
$1.68
Dividend yield
—
52W range
$19 – $33
Volume
1.5M
Catalyst Pharmaceuticals Inc (CPRX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$28.26
12-Month target
$21.59
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.2B | $0.4B | $0.5B | $0.6B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 16.82x (capped 25x) · Margin: 36.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.